Technical Analysis for FOMX - Foamix Pharmaceuticals Ltd.

Grade Last Price % Change Price Change
grade F 2.61 -4.04% -0.11
FOMX closed down 2.57 percent on Monday, May 20, 2019, on 73 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical FOMX trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion -1.51%
1,2,3 Retracement Bearish Bearish Swing Setup -4.04%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.04%
Lower Bollinger Band Walk Weakness -4.04%
Wide Bands Range Expansion -4.04%
Lower Bollinger Band Walk Weakness -1.88%
Outside Day Range Expansion -1.88%
Wide Bands Range Expansion -1.88%
Lower Bollinger Band Touch Weakness -1.88%
NR7 Range Contraction -2.61%

Older signals for FOMX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Foamix Pharmaceuticals Ltd., a clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. Its lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. The company is also developing FMX101 to treat rosacea; and FDX104 to treat chemotherapy-induced rashes, as well as early-stage foam formulations of various drugs for the treatment of dermatological indications, including antibacterial drugs, antifungal drugs, corticosteroids, and immunomodulators. Foamix Pharmaceuticals Ltd. has development and license agreements Bayer AG, Merz Pharmaceuticals, LLC, Actavis plc, Prestium Pharma, Inc. and Arkin Holdings Ltd., and others. It has operations in the United States, Germany, and Israel. The company was founded in 2003 and is headquartered in Rehovot, Israel.
Pharmaceutical Chemotherapy Acne Rosacea Anti Acne Preparations Impetigo
Is FOMX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.6
52 Week Low 2.4
Average Volume 293,886
200-Day Moving Average 4.2909
50-Day Moving Average 3.5032
20-Day Moving Average 3.034
10-Day Moving Average 2.812
Average True Range 0.2025
ADX 42.29
+DI 7.069
-DI 27.7258
Chandelier Exit (Long, 3 ATRs ) 2.8425
Chandelier Exit (Short, 3 ATRs ) 3.0075
Upper Bollinger Band 3.5589
Lower Bollinger Band 2.5091
Percent B (%b) 0.13
BandWidth 34.601187
MACD Line -0.2441
MACD Signal Line -0.2159
MACD Histogram -0.0282
Fundamentals Value
Market Cap 99.18 Million
Num Shares 37.4 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -1.99
Price-to-Sales 40.32
Price-to-Book 2.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.89
Resistance 3 (R3) 2.89 2.81 2.85
Resistance 2 (R2) 2.81 2.75 2.81 2.84
Resistance 1 (R1) 2.73 2.71 2.69 2.73 2.82
Pivot Point 2.65 2.65 2.63 2.65 2.65
Support 1 (S1) 2.57 2.59 2.53 2.57 2.48
Support 2 (S2) 2.49 2.55 2.49 2.46
Support 3 (S3) 2.41 2.49 2.45
Support 4 (S4) 2.41